Latest Prescription Drugs news
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
posted July 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Amivantamab-Lazertinib Ups Survival in EGFR-Mutated Advanced Lung Cancer
posted July 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
NCCN: Cancer Drug Shortages Remain a Challenge for Clinicians
posted June 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Obesity Linked to Early-Onset Cancer Risk in Young Adults 
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers Related Articles
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria Monthly Specialist Briefings
Stay Connected
